Skip to main content
ALHC logo

ALHC · Alignment Healthcare, Inc.

Track ALHC — free
$7.43 +0.07 (+0.88%)
Market Cap
$1.54B
Shares
209.27M
Volume · Nov 16 1.33M Avg daily vol (3M) 7.97M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$7.36 Open$7.57 Day$7.23–7.57 52W close$7.00–24.56 Avg vol 30d6.9M Short int23.1M · 11.1% of shares · 3.9d Short vol47% Last earningsOct 29, 2026 DataMar 2021–Nov 2026 Filing10-Q · Oct 29

Up next

Feb 25, 2027 Est · unconfirmed · in 14 wks

Latest documents

2026
Oct 29
Earnings call
Q3 2026 earnings call

Alignment Healthcare reported third-quarter 2026 revenue of $1.4 billion and adjusted EBITDA of $22 million, lowering full-year 2026 guidance to adjusted gross profit of no less than $575 million and adjusted EBITDA of no less than $100 million amid elevated medical costs.

Oct 29
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Membership grows 31.2% amid third-quarter net loss

Alignment Healthcare reported Health Plan membership of 301,200 at September 30, 2026, up 31.2% from a year earlier. For the three months ended September 30, 2026, revenue was 1,358,290 and net loss was 8,052, in thousands of dollars.

Revenue $1.36B ▲ 36.7% Net loss $8.05M Diluted EPS -$0.04
Read from the MD&A section
5 source passages
Alignment Healthcare, Inc. and its consolidated subsidiaries. As of September 30, 2026, we have approximately 301,200 Health Plan Members The increase was primarily driven by growth in our Health Plan membership, which increased 31.2% between September 30, 2025 and September 30, 2026. | Revenues | 1,358,290 | | 993,695 | | 36.7% | 3,929,120 | | 2,935,915 | | 33.8% | | Net income (loss) | (8,052) | | 3,729 | | (315.9)% | 39,924 | | 10,028 | | 298.1% | Open the document at this passage
Oct 29
Current report 8-K
Financial results

Alignment Healthcare, Inc. reported third-quarter revenue of $1,358.3 million, up 36.7% year-over-year, and health plan membership of approximately 301,200, up 31.2%. It lowered fiscal-year 2026 adjusted gross profit and adjusted EBITDA guidance due to higher medical costs.

Oct 8
Current report 8-K
Regulation FD disclosure

Alignment Healthcare expects California HMO health plan contract H3815 to have a 3.5-Star Rating for rating year 2027, down from 4.0-Star Rating for rating year 2026; the change will affect fiscal year 2028 quality bonus payments.

All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$4.94B
Trailing 12 months
Net income (TTM)
$28.92M
Trailing 12 months
Revenue growth YoY
+36.7%
Year over year
Operating margin
0.9%
Trailing 12 months
P / E (TTM)
52.6
Trailing earnings · reciprocal yield 1.9%
FCF yield
5.0%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$418.46M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-0.2%
Year over year · fewer shares
Price change (1Y)
-56.1%
Trailing year
Short interest
11.1%
Latest settlement · 3.9 days to cover
View all 125 metrics

AI Brief

Q3 FY26 earnings call · Oct 29, 2026
Q3 FY26

TL;DR. Growth remained strong, with revenue up 36.7%, membership up 31.2%, adjusted gross profit up 11.6%, improved operating efficiency, strong cash generation, raised full-year membership and revenue guidance, and management targeting at least 20% top-line growth in 2027. However, higher medical costs, a 3.5-star California HMO rating, and weaker quarterly profitability pressured results, prompting lower full-year profit guidance and negative fourth-quarter adjusted EBITDA guidance.

Bullish
  • + Third-quarter revenue increased 36.7% year-over-year to $1,358.3 million.
  • + Health plan membership increased 31.2% year-over-year to approximately 301,200 members.
  • + Adjusted FG&A was 8.9% of revenue, improving 70 basis points year-over-year and outperforming the guidance midpoint by approximately 90 basis points.
  • + The company generated $158 million of operating cash flow during the first nine months and described its liquidity profile as strong.
  • + Management said it remained positioned to target at least 20% top-line growth in 2027 based on early AEP results.
  • + Full-year 2026 membership and revenue guidance was raised to reflect continued sales momentum.
Bearish
  • − Full-year 2026 adjusted gross profit and adjusted EBITDA guidance was lowered.
  • − The adjusted medical benefits ratio increased approximately 240 basis points year-over-year to 89.5%, reflecting elevated appeals and disputes and higher catastrophic-case and skilled-nursing costs.
  • − Adjusted EBITDA declined 32.8% year-over-year to $21.8 million, and the company reported a net loss of $8.1 million.
  • − The California HMO contract earned a 3.5-star rating, below management's expectations.
  • − Fourth-quarter guidance called for adjusted EBITDA of no less than negative $28 million.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Excellent Quant / Vol Very High
Market backdrop VIX 19.3 · elevated Equity put/call 0.63
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −54%
below
Price vs 50-day avg −15%
below
RSI (14) 41
neutral
MACD trend Positive
52-week position 2%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −11%
trailing
6-month return −54%
trailing
YTD return −63%
this year
Relative strength −55%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $9 › 200d $16 — 200d above 50d
Institutional flow Distributing
286 of 332 funds reported for Sep 30 · net -4.8M sh shares · +41 new
Insider flow Distributing
Net -$2.1M over 90 days · 100% sells
Short interest Falling
11.06% of shares out · ▼ -9.3% MoM · 3.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
332 holders — near 3-yr high, broad support
Squeeze score 55
elevated · 0–100
Fundamentals
Excellent
Revenue growth +46%
Y/Y
EPS growth +100%
Y/Y
Free cash flow $113.1M
Balance sheet $252.6M
net cash
Quant / Vol
risk profile
Very High
Volatility 72%
annualized · 1-yr
Max drawdown −72%
past year
ATR 7.1%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 7 of last 7
Latest guidance · from the Earnings Call filed Jul 30, 2026
full-year
Revenue Raised $5.2B
Apr 30, 2026 $5.16B – $5.21B changed to Jul 30, 2026 $5.2B
prior FY $3.95B midpoint +31.7% Y/Y
2027
Enrollment growth 20%
Previous outlook earlier release · from the Earnings Call filed Apr 30, 2026

Still-open targets the latest release did not restate under the same label.

Adjusted gross profit · full year 2026 $620M – $650M
Adjusted EBITDA · full year 2026 $138M – $163M
Prior guidance period ended · from the Earnings Call filed Apr 30, 2026
Revenue · second quarter $1.3B – $1.32B
Adjusted gross profit · second quarter $167M – $177M
Adjusted EBITDA · second quarter $50M – $60M
Guided vs delivered · last 7 settled
Revenue second quarter
guided $1.3B – $1.32B
$1.34B Beat +2.0%
Revenue fourth quarter
guided $995M – $1.01B
$1.01B Beat +1.0%
Revenue full year 2025
guided $3.93B – $3.95B
$3.95B In line
Revenue fourth quarter of 2021
guided $265M – $270M
$298.27M Beat +11.5%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−54% Bearish
Price vs 50-day avg
−15% Bearish
RSI (14)
41 Neutral
MACD trend
Positive Bullish
52-week position
2% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $9 › 200d $16 — 200d above 50d
Institutional flow Distributing
286 of 332 funds reported for Sep 30 · net -4.8M sh shares · +41 new
Insider flow Distributing
Net -$2.1M over 90 days · 100% sells
Short interest Falling
11.06% of shares out · ▼ -9.3% MoM · 3.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
332 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $7 Now $7 · 2% Range high $25
vs 200-day avg -54% vs 50-day avg -15%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted EBITDA non-GAAP $68.1M Q2 FY2026 —
GAAP → non-GAAP reconciliation
GAAP Net income 36.56M
+0K Net loss attributable to noncontrolling interest
+4.28M Interest expense
+7.86M Depreciation and amortization
+1.27M Income tax expense
+18.17M Equity-based compensation
+14K Litigation costs
-1K Gain on sale of property and equipment
= Adjusted EBITDA 68.15M
Adjusted EBITDA margin non-GAAP 5.1% Q2 FY2026 —
Adjusted gross profit non-GAAP $182.9M Q2 FY2026 —
GAAP → non-GAAP reconciliation
GAAP Income from operations 42.1M
+1.89M Equity-based compensation (medical expenses)
+3K Depreciation (medical expenses)
+7.85M Depreciation and amortization
+131M Selling, general, and administrative expenses
= Adjusted Gross Profit 182.85M
Health plan membership 294,100 Q2 FY2026 —
Medical benefits ratio 86.3% Three Months Ended June 30, 2026 filing —
Medical benefits ratio based on adjusted gross profit non-GAAP 86.3% Q2 FY2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Healthcare Plans — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
ALHC
Alignment Healthcare, Inc.
this stock
$1.54B -62.7% +46.1% — 11.1%
UNH
Unitedhealth Group Inc
$365.09B +23.4% +11.8% 23.3 1.6%
CVS
CVS HEALTH Corp
$114.32B +12.6% +7.8% 10.4 1.4%
ELV
Elevance Health, Inc.
$92.84B +22.6% +12.5% 18.3 2.1%
CI
Cigna Group
$78.26B +7.9% +11.2% 13.1 2.4%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
335
% held
103.9%
Reported
286 of 332
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
388
View
Short & Settlement
Short Interest Falling
Shares short
23.1M
Days to cover
3.9d
Change
-2.4M sh
View
Short Volume
Short vol %
47%
As of
Nov 13, 2026
Short Total
View
Fails to Deliver
FTD shares
678
Value
$5.7K
As of
Oct 22, 2026
View
Off-Exchange
Off-exchange %
43.0%
Week of
Oct 12, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$2.1M
Buyers / Sellers
0 / 3
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$3.9B
Net income (FY)
$-724.0K
EPS diluted
$0.00
View
Filings
SEC Filings
Latest
8-K
Filed
Oct 29, 2026
This year
23

Alignment Healthcare, Inc. reported third-quarter revenue of $1,358.3 million, up 36.7% year-over-year, and health plan membership of approximately 301,200, up 31.2%. It lowered fiscal-year 2026 adjusted gross profit and adjusted EBITDA guidance due to higher medical costs.

View
Proposed Sales
Value
$6.5M
Shares
500.0K
Filed
Sep 10, 2026
View
Earnings & Events
Webcasts
Last webcast
Oct 29, 2026
View
Investor Relations
Latest news
Survey Suggests a Simple Beverage…
Published
Nov 10, 2026
View

Performance

5D 20D 120D MTD YTD
ALHC +0.3% -11.1% -54.1% +1.2% -62.7%
SPY +2.6% -1.2% +0.5% -0.2% +10.6%
vs SPY -2.3% -10.0% -54.6% +1.4% -73.4%
Key facts CIK 1832466 CUSIP 01625V104 13F (30d) 248 filings 230 filers Visit website Investor relations